Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01950351 · ClinicalTrials.gov registry record · Phase 1
Hypofractionated Proton Beam Therapy for Localized Prostate Cancer
A Phase 1 study of Stage II Prostate Adenocarcinoma AJCC v7 and Stage I Prostate Adenocarcinoma AJCC v7, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- Phase 1
- Development phase
- 241
- Enrollment target
- 1
- Study location
NCT01950351 is a Phase 1 study of Stage II Prostate Adenocarcinoma AJCC v7 and Stage I Prostate Adenocarcinoma AJCC v7 that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 241 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01950351, a Phase 1 study of Stage II Prostate Adenocarcinoma AJCC v7 and Stage I Prostate Adenocarcinoma AJCC v7, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 241 participants
- Enrollment target
- 1
- Study location
Study Summary
This phase II trial studies the side effects and how well hypofractionated proton beam radiation therapy works in treating patients with prostate cancer that has not spread to nearby lymph nodes or to other parts of the body. Specialized radiation therapy, such as proton beam radiation therapy, that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Laboratory Biomarker Analysis
- RADIATION Proton Beam Radiation Therapy
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 241 participants |
| Start Date | 2013-10-10 |
| Est. Completion | 2028-06-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01950351
The ClinicalTrials.gov registry entry for NCT01950351 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 241 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Stage II Prostate Adenocarcinoma AJCC v7 appearing as the primary indexed condition, and to 3 interventions - of which Quality-of-Life Assessment is the first listed.
NCT01950351 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01950351 about?
NCT01950351 is a clinical study titled "Hypofractionated Proton Beam Therapy for Localized Prostate Cancer". This phase II trial studies the side effects and how well hypofractionated proton beam radiation therapy works in treating patients with prostate cancer that has not spread to nearby lymph nodes or to other parts of the body. Specialized radiation therapy, such as proton beam radiation therapy, that...
What is the current status of trial NCT01950351?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 241 participants. The study started on 2013-10-10. Estimated completion is 2028-06-01.
What conditions does trial NCT01950351 study?
This clinical trial studies the following conditions: Stage II Prostate Adenocarcinoma AJCC v7, Stage I Prostate Adenocarcinoma AJCC v7.
What interventions are being tested in trial NCT01950351?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Laboratory Biomarker Analysis (OTHER), Proton Beam Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT01950351?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01950351 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage II Prostate Adenocarcinoma AJCC v7
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
ACTIVE NOT RECRUITING · Phase 3
-
Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Stage II Prostate Adenocarcinoma AJCC v7
All registered trials for this condition
Stage I Prostate Adenocarcinoma AJCC v7
All registered trials for this condition
Texas
All trials with a study site in Texas
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.